This is a working overview of hexenoyl group, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-06-22. Anything still debated is marked as such rather than presented as settled.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
Common analytical approaches include reversed-phase high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Peptide mapping after enzymatic digestion can verify the expected sequence. Immunoassays may be used to measure the compound or its downstream markers, but they can cross-react with related peptides and require careful validation. Impurity profiles typically include truncated sequences, oxidized methionine residues, and residual solvents from synthesis. Each method reports a different property, so no single assay establishes overall quality.
Storage claims vary across suppliers, and published stability data for specific formulations are limited. Extrapolating from related peptides is common but not a substitute for direct measurement. For research use, documentation such as a certificate of analysis is often requested to confirm identity and purity. What constitutes an acceptable purity threshold depends on the intended application. Open questions remain about how temperature excursions during shipping affect long-term peptide integrity. Independent verification by an end user is not routinely reported.
Lyophilized tesamorelin is generally stored refrigerated at 2 to 8 degrees Celsius, protected from light and moisture. Peptides in this class are often kept frozen at minus 20 degrees Celsius for longer periods. Reconstituted solutions are typically used within a defined window because hydrolysis and oxidation proceed faster in liquid form. Container material and headspace also influence how long a preparation retains its expected profile. Specific stability figures depend on concentration and buffer composition.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
University of Western Ontario (LL.D.) on May 30, 1924 University of Toronto (D.Sc.) in 1924 Queen's University (LL.D.) in 1924 University of Michigan (LL.D.) in 1924 Yale University (D.Sc.) in 1924 University of the State of New York (D.Sc.) in 1931 McGill University (D.Sc.) in 1939
==== Inert ==== Inert IUDs are not approved for use in the United States, the UK, or Canada. Inert IUDs do not have a bioactive component. They are made of inert materials such as stainless steel or plastic. Their primary mechanism of action is to cause a local foreign body reaction, which makes the uterine environment hostile to both sperm and implantation. They may have higher rates of preventing pregnancy after fertilization, instead of before fertilization, compared to copper or hormonal IUDs.
A seismic metamaterial is a metamaterial that is designed to counteract the adverse effects of seismic waves on artificial structures. Current designs of seismic metamaterials use configurations of boreholes, trees, or proposed underground resonators to act as a large-scale material. Experiments have observed both reflections and bandgap attenuation from artificially induced seismic waves. These are the first experiments to verify that seismic metamaterials can be measured for frequencies below 100 Hz, where damage from Rayleigh waves is the most harmful to artificial structures.
The 7 kDa DNA-binding proteins are a family of DNA-binding proteins from Sulfolobales archaea. These proteins bind DNA in a mostly sequence-independent manner, with some preference for G/C rich regions and affinities that differ from each other. They serve a genome-packaing purpose analogous to histones. They are resistant to high temperatures as well as low and high pH.
Sources: en.wikipedia.org
27 May – A study published in Light: Science & Applications describes an additive-free, brine-discharge-free solar-thermal desalination method that uses femtosecond laser-etched superwicking black metal to produce fresh water from real ocean water while collecting nearly all remaining salts as solids. Tests using samples from the Pacific, Atlantic, and Indian Oceans show that the self-cleaning surface can prevent salt and mineral build-up, a major limitation of existing solar desalination systems. 31 May – A Phase 3 trial published in the New England Journal of Medicine reports that daraxonrasib, an investigational oral RAS(ON) inhibitor, nearly doubles median overall survival in patients with previously treated metastatic pancreatic cancer, from 6.6 months with standard chemotherapy to 13.2 months.
Continuous-wave lasers however are often preferred to pulsed lasers due to the latter's relatively low duty cycle since they can only produce photo ions during the brief later pulses, and the difficulty in reproducing results due to pulse-to-pulse jitters, laser beam drifting, and wavelength variations. Moderate laser powers, if high enough to affect the desired transition states, can be used since the non-resonant photoionization cross section is low which implies a negligible ionization efficiency of unwanted atoms. The influence of the laser matrix to be used for the sample can also be reduced by separating evaporation and ionization processes both in time and in space. Another factor that could affect the efficiency and selectivity of the ionization process is the presence of contaminants caused by surface or impact ionization. This can be reduced up to appreciable orders of magnitude by using mass analysis so that isotopic compositions of the desired element are determined. Most of the elements of the Periodic Table can be ionized by one of the several excitation schemes available. The suitable excitation scheme depends on certain factors including the level scheme of the element's atom, its ionization energy, required selectivity and sensitivity, likely interference, and the wavelengths and power levels of the available laser systems. Most excitation schemes vary in the last step, the ionization step. This is due to the low cross-section for non-resonant photo-ionization produced by the laser.
== Further reading == May RM, Anderson RM (1991). Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press. ISBN 0-19-854040-X. Vynnycky E, White RG, eds. (2010). An Introduction to Infectious Disease Modelling. Oxford: Oxford University Press. ISBN 978-0-19-856576-5. Capasso V (2008). Mathematical Structures of Epidemic Systems. 2nd Printing. Heidelberg: Springer. ISBN 978-3-540-56526-0. Carlson CS, Rubin DM, Heikkilä V, Postema M (2021). "Extracting transmission and recovery parameters for an adaptive global system dynamics model of the COVID-19 pandemic". 2021 IEEE Africon (PDF). pp. 456–459. doi:10.1109/AFRICON51333.2021.9570946. ISBN 978-1-6654-1984-0. S2CID 239899862.
== Education == Chandan Sen earned his Bachelor of Science degree (Honors in Physiology) in 1987 and his Master of Science in Human Physiology in 1990 from the Rajabazar Science College at Calcutta University. He subsequently moved to Finland for advanced studies and received his Ph.D. in Physiology in 1994 from the School of Medicine at the University of Eastern Finland (Kuopio Campus). In January 1995, Sen joined the University of California, Berkeley for postdoctoral research in the Department of Molecular and Cell Biology, focusing on redox signaling (1995–1996). In 1997, Sen accepted his first faculty appointment at the Lawrence Berkeley National Laboratory in Berkeley, California.
Aflatoxins are various poisonous carcinogens and mutagens that are produced by certain molds, especially Aspergillus species such as Aspergillus flavus and Aspergillus parasiticus. According to the USDA, "They are probably the best known and most intensively researched mycotoxins in the world." The fungi grow in soil, decaying vegetation and various staple foodstuffs and commodities such as hay, maize (corn), peanuts, coffee, wheat, millet, sorghum, cassava, rice, chili peppers, cottonseed, tree nuts, sesame seeds, sunflower seeds, and various cereal grains and oil seeds. They have been found in both pet and human foods, as well as in feedstocks for agricultural animals. Animals fed contaminated food can pass aflatoxin transformation products into milk, milk products, and meat. For example, contaminated poultry feed is the suspected source of aflatoxin-contaminated chicken meat and eggs in Pakistan. Children are particularly vulnerable to aflatoxin exposure, which is linked to immune suppression, stunted growth, delayed development, aflatoxicosis, and liver cancer. Some studies have reported an association between childhood stunting and aflatoxin exposure, although this link has not been consistently detected in all studies. Furthermore, a causal relationship between childhood stunting and aflatoxin exposure has yet to be conclusively shown by epidemiological studies, though such investigations are underway. Adults have a higher tolerance to exposure, but are also at risk. No animal species is known to be immune. Aflatoxins are among the most carcinogenic substances known.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
Refrigeration between 2 and 8 degrees Celsius with protection from light is the common recommendation. Many laboratories choose frozen storage at minus 20 degrees Celsius when the material will not be used soon. Repeated temperature cycling is generally avoided.